Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Digestive Surgery|March 12, 2009
Serum obestatin/ghrelin ratio is altered in patients after distal gastrectomySung Kim, Jun Haeng Lee, Jin Seok Heo, et al.
The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
Correlation between fasting plasma ghrelin levels and age, body mass index (BMI), BMI percentiles, and 24-hour plasma ghrelin profiles in Prader-Willi syndromeKyung Hoon Paik, Dong-Kyu Jin, Sang Yong Song, et al.
The Journal of Clinical Endocrinology and Metabolism|January 20, 2005
Hyperghrelinemia does not accelerate gastric emptying in Prader-Willi syndrome patientsYon Ho Choe, Dong-Kyu Jin, Sang Eun Kim, et al.
Cancer Medicine|May 17, 2018
Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian databaseHaider H Samawi, Hao-Wen Sim, Kelvin K Chan, et al.
Journal of Surgical Oncology|October 23, 2020
Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort studyHala Muaddi, Michael D'Angelica, Jason T Wiseman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 9, 2024
2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patientsSamantha K F Kennedy, Shannon Goodall, Shing Fung Lee, et al.
Clinical Colorectal Cancer|April 15, 2018
A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group TrialDerek J Jonker, Patricia A Tang, Hagen Kennecke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancerMary-Ellen Taplin, Meredith M Regan, Yoo-Joung Ko, et al.
Therapeutic Advances in Medical Oncology|October 10, 2024
Pan-Canadian consensus recommendations for GIST management in high- and low-throughput centres across CanadaJ Robert Beecroft, Savtaj Brar, Xiaolan Feng, et al.
Clinical Colorectal Cancer|June 22, 2019
Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)Rachel P Riechelmann, Vichien Srimuninnimit, Roberto Bordonaro, et al.
Pageof 7